Improving the effectiveness of smoking cessation in primary care: Lessons learned

New Zealand Medical Journal

Volumn 116, Issue 1173, 2003, Pages

  Richards, Dee A ^a   Toop, Les J ^a   Brockway, Keith ^b   Graham, Sue ^c   McSweeney, Bill ^b   MacLean, Donna ^b   Sutherland, Margaret G ^a   Parsons, Alison ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Pegasus Health IPA ^*

^c PEGS Smoking Cessation Programme

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; ETHNOLOGY; FEMALE; GENERAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH HAZARD; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREDICTION; PRIMARY HEALTH CARE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; URBAN AREA; ANALYSIS OF VARIANCE; EVALUATION; HEALTH CARE QUALITY; METHODOLOGY; MIDDLE AGED; QUESTIONNAIRE; STATISTICS;

NICOTINE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; FAMILY PRACTICE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NICOTINE; PRIMARY HEALTH CARE; PROGRAM EVALUATION; QUESTIONNAIRES; SMOKING CESSATION;

EID: 0037646833     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries 1950-2000: indirect estimates from national vital statistics. Oxford: Oxford University Press; 1994.
2. Lennox AS, Osman LM, Reiter E, et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. BMJ 2001;322:1396.
3. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-6.
4. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 2001.
5. Stapleton JA, Lowin A, Russell MA. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 1999;354:210-5.
6. de Zwart KM, Sellman JD. Public knowledge and attitudes regarding smoking and smoking cessation treatments. NZ Med J 2001;115:219-22.
7. McLeod D, Somasundaram R, Howden-Chapman P, Dowell AC. Promotion of smoking cessation by New Zealand general practitioners: a description of current practice. N Z Med J 2000:113;480-2.
8. Mendelsohn C, Richmond RL. Smokescreen for the 1990s. A new approach to smoking cessation. Aust Fam Physician 1994;23:841-8.
9. DiClemente CC, Prochaska JO, Fairhurst SK, et al. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 1991;59:295-304.
10. Town GI, Fraser P, Graham S, et al. Establishment of a smoking cessation programme in primary and secondary care in Canterbury. NZ Med J 2000;113:117-9.
11. US Preventive Services Task Force. Guide to clinical preventive services. 2nd edition. Baltimore: Williams & Wilkins; 1996.
12. Crampton P, Salmond C, Sutton F. NZDep 96 index of deprivation. Wellington: Health Services Research Centre, Victoria University; 1998.
13. Gardner S, Winter P, Gardner M. Confidence interval analysis version 1.1 with: statistics with confidence. London: BMJ; 1989.
14. Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the ahcpr guideline for smoking cessation. JAMA 1997;278:1759-66.
15. New Zealand National Health Committee. Guidelines for Smoking Cessation. Wellington: National Health Committee 2002.